Adeona Pharmaceuticals Inc Blog | Talkmarkets | Page 1
No data available
No data available
Latest Posts
1 to 8 of 8 Posts
Mizuho Says Synthetic Biologics IBS Treatment May Be 'Interesting' For Valeant
Article By: The Fly Friday, June 29, 2018 3:13 PM EDT
Mizuho analyst Irina Koffler raised her price target for Valeant Pharmaceuticals.
In this article: VRX, SYN
Read
Synthetic Biologics & Proteon Therapeutics Stock Prices Soar 30% & 45%, Respectively, On News Of Designations From The FDA
Article By: Lorimer Wilson Thursday, May 11, 2017 10:17 AM EDT
The FDA handed out new breakthrough therapy designations for a whole slate of biotech drugs in the clinic and investors are still cheer each announcement with a big spike in stock prices: PRTO stock went up 46% on Wednesday; SYN's is up 30% today.
In this article: PRTO, CRBP, SYN
Read
E Forecasts And Recoupling
Article By: Vivian Lewis Wednesday, February 3, 2016 3:21 PM EDT
Yesterday's market closed barely dented by the renewed drop in the oil price, leading some experts to say this new linkage was now ended. The decoupling was ended in spades, with markets tumbling.
In this article: BP, TTM, FCAU, DGRLY, CZZ, SLB, CCJ, VE, TEVA, SYN, GSK, BSBR, BNS, LBTYA, VOD, PSHZF, NOK, VRX, PAH, EXG, ETW, PT, CVC, SAN
Read
E Synthetic Biologics Sinks 14% On Phase 2 Trial Failure For Relapsing-Remitting Multiple Sclerosis
Article By: Terry Chrisomalis Wednesday, February 3, 2016 2:39 AM EDT
With these clinical findings, the company has chosen to abandon the Trimesta program and focus clinical resources on two gut microbiome programs.
In this article: SYN
Read
E Synthetic Biologics Announces Positive Phase 2 Results For Prevention Of Bacterial Infection
Article By: Terry Chrisomalis Tuesday, December 1, 2015 8:30 PM EDT
Synthetic Biologics announces positive phase 2 results for prevention of bacterial infection
In this article: SYN
Read
Don’t Miss Out, Buy These 2 Hot Biotech Stocks Under $3
Article By: Bret Jensen Saturday, September 26, 2015 8:08 PM EDT
These stocks might not be trading this low ever again. Both have big upcoming catalysts that could skyrocket their shares up double digits in just one day, and have just what I look for in finding the most successful small cap biotech stocks.
In this article: OGXI, SYN Also: TEVA
Read
Thursday Morning Pre-Market Insights: NFLX, ANFI, SYN, GRMN
Article By: TipRanks Thursday, July 16, 2015 9:30 AM EDT
Thursday Morning Pre-Market Insights: Netflix, Inc., Amira Nature Foods Ltd, Synthetic Biologics Inc., Garmin Ltd.
In this article: ANFI, GRMN, NFLX, SYN
Read
E Synthetic Biologics: A Compelling Biotech With A Low Valuation
Article By: Trevor Lowenthal Friday, December 26, 2014 2:28 PM EDT
Synthetic Biologics has various opportunities in several lucrative clinical indications. The surprising thing is that the biotech has an incredibly low valuation compared to its competitors.
In this article: SYN
Read
1 to 8 of 8 Posts